State of the Art: Treatment of ANCA-Associated Vasculitis in 2020

Moderator(s)

• 

  Saira Sheikh, MD

  Assistant Professor of Medicine
  University of North Carolina at Chapel Hill

Speaker(s)

• 

  Sharon Chung, MD

  University of California, San Francisco

The year is 2020. Much progress has been made in the treatment of ANCA-associated vasculitis and new treatment options are on the horizon. This session will be a comprehensive overview of recently studied therapies for ANCA-associated vasculitis, cover the role of biomarkers in the management of this disease and review novel therapeutic strategies.

Learning Objectives:

• Assess the efficacy of recently studied therapies for ANCA-associated vasculitis
• Discuss the role of biomarkers in the management of ANCA-associated vasculitis
• Describe novel therapeutic strategies for the treatment of ANCA-associated vasculitis

Presentations:

• 5:15 PM – 5:45 PM ET

  State of the Art: Treatment of ANCA-Associated Vasculitis in 2020
  Sharon Chung, MD – University of California, San Francisco
• 5:45 PM – 6:00 PM ET

  Q&A